Two indirect enzyme-linked immunosorbent assays (I-ELISAs) are described for the detection of bovine serum antibody to the New Jersey (NJ) and Indiana (IN) vesicular stomatitis viruses (VSV). Serum samples at a dilution of 1:200 were incubated with binary ethylenimine-inactivated VSV-NJ and VSV-IN typespecific antigens preadsorbed to microtiter plates. Bound antibodies were detected by a murine monoclonal antibody to bovine IgG 1 conjugated with horseradish peroxidase. The performance of each I-ELISA in detecting homotypic and heterotypic antibodies to VSV-NJ and VSV-IN in sequential serum samples from calves experimentally infected with VSV-NJ or VSV-IN was evaluated. The I-ELISAs detected serotype-specific antibodies to either VSV-NJ or VSV-IN in calves infected with the homologous serotype. Homotypic but not heterotypic anti-VSV-NJ antibodies were first demonstrable by the VSV-NJ I-ELISA during the second week postinfection and remained at an elevated level for a period of 11 weeks, with a gradual decrease thereafter. Similar homotypic antibody profiles measured by the VSV-IN I-ELISA in calves inoculated with VSV-IN were observed. The performances of the I-ELISAs were compared using 1,495 microtiter serum neutralization (MTSN) test-negative bovine field sera collected from cattle in Canada (VS free) and 429 samples collected from cattle in the USA and Mexico (VS-epidemic and VS-endemic areas). The diagnostic specificities of the VSV-NJ and VSV-IN I-ELISAs for the Canadian samples relative to the MTSN test results were in the range of 99.8% and 99.7%, respectively. The levels of agreement between the VSV-NJ and VSV-IN I-ELISAs and the MTSN test for the 429 bovine field samples from VS-epidemic and VS-endemic areas were 97.7% and 98.8%, respectively. Relative to MTSN, the sensitivity and specificity of the 429 field sera for the VSV-NJ I-ELISA were 95.4% and 99.6%, respectively, and for the VSV-IN assay were 75.0% and 99.2%, respectively. The results suggest that in addition to the many technical advantages over the MTSN test these I-ELISAs have potential application as rapid and inexpensive tests for the serodiagnosis of VSV infection in cattle.
the majority of epidemics and more severe clinical signs than the VSV-IN serotype. There has been no outbreak of VSV-IN infection in the USA since 1965. 16 In addition to a major outbreak in 1949, recent major epizootics in the USA of VSV-NJ infection have occurred in 1982-1983 17 and 1985-1987. 22 Since 1949, when the epizootic of VSV-NJ in the USA apparently reached Manitoba, 13 no clinical or serologic evidence of VS has been reported in Canada. The severe form of VSV infection in cattle and swine is indistinguishable from that produced by foot-and-mouth disease virus. However, during epizootics of VS in the USA 50-100% of cattle seroconverted to VSV without showing any clinical sign of the disease. 33, 35 VSV infection is most often diagnosed by isolation of virus and/or detection of viral antigens by complement fixation (CF) 6, 18 or enzyme-linked immunosorbent assay (ELISA). 10 Among the numerous serologic assays described for detection of antibody to VSV, 21, 34, 38 the CF and the microtiter serum neutralization (MTSN) are the most widely used. 12 The CF, although a good indicator of recent infection, is complex, is cumbersome to perform, requires titration of many reagents, and cannot be used with anticomplementary or hemo-lyzed sera. The serum neutralization (SN) test, however, can detect long-lasting type-specific neutralizing antibodies to VSV-NJ and VSV-IN 19 but has a number of inherent disadvantages, including the maintenance and use of live virus and cell culture capability. The SN test must be performed under aseptic conditions and requires biocontainment facilities, and the live virus used in the test constitutes a health hazard to the laboratory personnel. Some sera cannot be assayed because of their cytotoxic effect and the test requires at least 2-3 days for completion and does not lend itself to large scale application or automation. As altematives, 2 types of ELISAs have been reported for the detection of antibodies against VSV. In 1985, Vernon and Webb described an IgM antibody capture ELISA for diagnosis of recent VSV infection. 32 The assay was useful for the detection of specific antibodies against VSV-NJ and VSV-IN in the sera of experimentally and naturally infected animals. It also was sensitive, reliable, and rapid and demonstrated comparable performance to other tests, i.e., CF, indirect immunofluorescence, and plaque neutralization. In 1986, Workman et a1. 39 reported the development of an indirect ELISA (I-ELISA) with sensitivity comparable to that of the SN test in detecting cross-reacting antibodies to VSV-NJ and VSV-IN in bovine sera. Because the performance of the I-ELISA was assessed on a limited number of field bovine sera, we decided to develop I-ELISAs and compare their performance with the standard MTSN test for detection of anti-VSV-NJ and anti-VSV-IN antibodies. The present report summarizes our experience with the I-ELISA in the testing of sera from calves experimentally infected with VSV-NJ and VSV-IN and from field samples collected from infected herds during epizootics of VS in the USA and from cattle in Mexico (VS-endemic areas) and in Canada (VS-free population).
Materials and methods
Viruses and cell cultures. The Ogden strain of VSV-NJ a and the San Juan strain of VSV-IN b serotypes were propagated in Vero (African green monkey kidney) cells for the ELISA antigen production. Vero cells, in plastic roller bottles of 490 cm 2 surface area, were grown in Earle's minimal essential medium (MEM), pH 7.4, containing penicillin (100 units/ml), streptomycin (100 &ml), 1% nonessential amino acidq c and 10% fetal bovine serum (FBS) c free of bovine viral diarrhea virus (BVDV) and anti-BVDV antibodies. Following a wash with serum-free MEM, containing 0.002 M L-glutamine and antibiotics, each bottle was inoculated with 20 ml of VSV-NJ or VSV-IN diluted in MEM to contain 10 8.0 median tissue culture infected doses (TCID 50 ), giving a multiplicity of infection (MOI) of approximately 0.2. After an adsorption period of 90 min at 37 C, the cultures were maintained in MEM (80 ml) without FBS and rolled at 0.25 rev/ min. When an 80% cytopathic effect developed, approxi-mately 18-21 hr after inoculation, the cultures were harvested for VSV ELISA antigen preparation.
The harvested virus suspension of each serotype was pooled separately and centrifuged twice at 1,800 x g for 30 min at 5 C to remove cell debris. The supernatant fluids were concentrated approximately 13-fold using a concentrator d with a 10,000-Dalton retention membrane. The concentrated fluids were centrifuged at 50,000 x g for 90 min at 5 C in an ultracentrifuge, e using a fixed-angle rotor (T-647.5). The pellet was resuspended in 10 ml of 0.05 M Tris-HC1 buffer, pH 7.8, containing 0.013 M NaCl and 0.001 M ethylenediaminetetraacetic acid, kept at 5 C overnight, and then centrifuged at 1,800 x g for 20 min at 5 C to remove cellular debris. The resulting supernatant fluids from VSV-NJ, VSV-IN, and a similar preparation from uninfected Vero cells, containing 23.2, 28.7, and 20.7 mg/ml of total protein, respectively, were treated with 1 mM binary ethylenimine (BEI) 4 at 37 C for 24 hr to eliminate infectious viruses. These inactivated preparations were used as ELISA antigens in this study.
Serum samples. Sera from serial blood samples of calves experimentally infected with the Ogden strain of VSV-NJ (calf nos. 505701 and 27681) and the San Juan strain of VSV-IN (calf nos. 505932 and C-14-75) were studied. The details of the experimental infection, together with other serologic results, have been described previously. 5 A total of 1,925 bovine field sera were used to evaluate the performance of the I-ELISAs. These sera consisted of 1,495 samples from Canadian cattle (VS-free), representing 10% of a national survey panel, 100 samples from infected herds in the USA, f and 329 samples from cattle from Mexico. g ELISA procedure. The I-ELISA was based on a previously described procedure, 1 except that a murine monoclonal antibody (MAb) to bovine IgGl (heavy-chain specific) conjugated with horseradish peroxidase (HRP) 23 was used to detect bound bovine antibody. Optimal dilutions of the ELISA reagents were determined by checkerboard titration, 24 and the following protocol was adopted. Flat-bottom 96-well polystyrene plates h were optimally coated by passive adsorption with 100 µl/well of VSV-NJ, VSV-IN, or control cell antigen at a dilution of 1:1,000 in 0.06 M carbonate buffer, pH 9.6. After overnight incubation at 25 C, the wells were washed 4 times with 0.01 M phosphate-buffered saline (PBS), pH 7.2, containing 0.05% Tween 20 (PBST). Serum samples were tested at a single dilution of 1:200 in PBST containing 1% gelatin, i and 100-µ1 samples were applied in duplicate against the VSV-NJ, VSV-IN, and cell culture control antigen in a diagonal sample placement pattern. 29 Following an incubation period of 2-3 hr at 25 C, the wells were again washed and filled with 100 µl of a 1:2,400 dilution of HRP-MAb conjugate (M23 lot No. 6) j in PBST. After incubation for 1 hr at 25 C, the conjugate solution was discarded and the plates were again washed in PBST. The wells were filled with 100 µ1 of substrate solution containing 2.0 mM ABTS (2,2'azino[3-ethylbenzthiazolinesulfonic acid]) and 4 mM H 2 O 2 in 0.05 M citrate buffer, pH 4.2, and the plates were then shaken continuously at 25 C for approximately 10 min. Using a computer-assisted target timing protoco1, 40 decrease was observed for the remainder of the ex-MTSN test. The serum samples were assayed for neutralizing antibodies to VSV-NJ strain (VS 20-011-522) a and periment (23 weeks) (Fig. 2) . The homologous anti-VSV-IN strain (VS 20-001-022). a The MTSN tests were per-body profiles of calves inoculated with VSV-IN were formed according to a standard procedure established in our similar to those described for calves inoculated with laboratory, which was adapted from a previously described VSV-NJ for at least 47 days (length of the experiment). method, 26 using Vero (Maru) cells. Serum neutralization ti-However, following a challenge exposure with VSVters were expressed as the reciprocal of dilution of sample IN, a slight secondary response was demonstrable by that gave complete protection against the cytopathic effect I-ELISA in 1 calf (no. C. 14075) ( Fig. 3) . Generally, the of 1,000 TCID 50 of virus. Serum samples with MTSN titers homologous antibody profiles as measured by the ≥ 32 were considered positive.
Results
To confirm the usefulness of BEI-treated VSV antigens in the I-ELISA, serial dilutions of BEI-treated and nontreated VSV-NJ and VSV-IN antigens were reacted in several trials with their corresponding antisera raised in calves. No significant differences were demonstrable in I-ELISA activities (Fig. 1) . Hence, BEI-inactivated antigens were used throughout this study.
The humoral antibody profiles as measured by the I-ELISAs and MTSN tests in calves experimentally infected with VSV-NJ or VSV-IN are shown in Figs. 2 and 3, respectively. Similar to the MTSN test, the I-ELISA was serotype specific for detection of homologous antibodies in sera of calves exposed to VSV-NJ or VSV-IN strains. Homologous antibodies were demonstrable by I-ELISA and MTSN tests from 7 and 10 days postinfection in serum samples from calves inoculated with VSV-NJ ( Fig. 2) and VSV-IN (Fig. 3) , respectively. The homologous antibodies to VSV-NJ The performance of the I-ELISAs was compared with that of MTSN tests with 429 field sera ( Table 1) 
Discussion
Several modifications made to a previously described I-ELISA 39 resulted in improvement of the assay as reported here. The ELISA antigens were prepared in Vero cells maintained in serum-free medium, resulting in better quality antigens. The inactivation of the virus was not detrimental to the reactivity of the antigen in the assay (Fig. 1) . The use of BEI-inactivated VSV antigens in ELISAs allows these reagents to be handled in minimum containment laboratories without jeopardizing the health of the workers or livestock. The use of an HRP-labeled MAb to bovine IgGl facilitates standardization of the I-ELISAs and reduces test variability, which may be associated with different lots of commercial polyclonal enzyme conjugates. The MAb used in this study (M23) is used routinely in other ELISA tests (e.g., Brucella, epizootic hemorrhagic disease of deer) for antibody detection. 3 , 23 Currently, the MTSN test is the definitive, quantitative, and serotype-specific assay for serodiagnosis of VS 11, 26 The present study shows that the I-ELISA is a useful, rapid, and quantitative assay. The I-ELISA is as sensitive and serotype specific as the MTSN test in detecting antibodies to VSV-NJ and VSV-IN. Results were comparable to the MTSN test; homologous antibodies were demonstrable by I-ELISA as early as the second week after infection (Figs. 2, 3) . In accordance with a previous study, 39 once the VSV antibodies reached their peak, they remained relatively stable for about 11 weeks postinfection, after which time titers gradually decreased. Following the challenge inoculation, a secondary antibody response was demonstrable in sera from 1 calf inoculated with VSV-IN (Fig. 3) . A number of investigators have reported that following either an exposure to or vaccination with VSV, SN antibodies appear in the sera of cattle within 2 weeks and persist at least for 1 year. 11, 12, 28, 36 Comparable performance of the I-ELISA and MTSN test as reported here and elsewhere 39 suggests that a similar pattern of VSV antibody persistence may be measured using the I-ELISAs.
In contrast to a previous report, 39 cross-reactivity in sera collected from calves experimentally infected with VSV-NJ or VSV-IN was not demonstrated in the I-EL-ISAs under study. The nucleocapsid proteins of VSV-NJ and VSV-IN share common antigenic determinants, and these have been suggested as the cause of cross-reactivity between the 2 serotypes in CF and in immunodifhtsion tests. 8, 21 Although the procedure used for the preparation of ELISA antigen in this study is similar in principle higher MOI (0.2) for to that reported previously, 39 a virus propagation in the present study might have resulted in a higher proportion of "defective" viral particles. A higher MOI in VSV propagation in cell culture results in a higher number of viral particles that have certain genomic defects, including a defect in the gene responsible for cross-reacting nucleocapsid proteins. 15 However, polyacrylamide gel electrophoresis 2 0 of the ELISA antigens used in this study showed, in addition to high levels of G proteins, low levels of L, N, NS, and M proteins, possibly originating from nondefective viral particles (unpublished data).
In the present study, the performance of the I-EL-ISAs in the serologic diagnosis of VSV infection was evaluated on a large number of field sera collected from VS-free (Canada) and VS-endemic (USA and Mexico) cattle populations. Serum screening dilutions ranging from 1:10 to 1:20 have been reported for VSV ELISAS 32, 39 We found that a dilution of 1:200 suitably minimizes nonspecific background activity of VSV antibody-negative sera in the I-ELISA. At this dilution, 3 and 4 samples of 1,495 MTSN-negative sera demonstrated OD readings above the negative cutoff values for the VSV-NJ and VSV-IN I-ELISAs, respectively. Except for 2 serum samples with OD values of 0.093 and 0.081, the I-ELISA absorbance values of 6 of these false-negative sera were well below the 0.10 cutoff value. Hence, the lower sensitivity of the VSV-NJ I-EL-ISA may be due to the differences in the dilution factor used for screening sera in each test. In Canada (VS free), a highly specific ELISA, as developed here, is the most desirable test . 31 Screening serum samples at a lower dilution (e.g., 1:20) may result in a higher sensitivity at the expense of a lower specificity. 2, 39 The 1 sample classified as VSV-N J I-ELISA positive/MTSN negative had an absorbance value of 0.14, close to the 0.10 cutoff value. This sample was positive in the VSV-IN I-ELISA and had a high level of neutralizing antibody to VSV-IN with a titer of 1:1,024 but had no demonstrable neutralizing antibody to VSV-N J serotype. Some bovine sera with high levels of heterologous neutralizing antibodies to VSV serotypes not only had high OD values in the I-ELISAs for their homologous antigens but also had high OD values in the heterologous assay. Further 2-or 4-fold dilution (i.e., 1:400 and 1800) of such false-positive samples eliminated the heterologous ELISA reaction, and yet these samples retained their activity with the homologous antigen (unpublished data).
The level of agreement between the VSV-IN I-EL-ISA and MTSN test for the 429 bovine field sera collected from cattle in VS-endemic areas ( Table 1) were also good (98.8%). Five serum samples had discrepant results. Relative to the MTSN test, the specificity and sensitivity estimates of the VSV-IN I-ELISA were 99.2% and 75.0%, respectively. The VSV-IN I-ELISA absorbance values of 3 MTSN negative/ELISA positive samples ranged from 0.24 to 0.43. Two VSV-IN MTSN positive/ELISA negative samples had a low level (1:32) of neutralizing antibody to VSV-IN. Because we had access to only 8 MTSN-positive samples for this study, more field samples from cattle exposed to VSV-IN should be tested to define a more accurate and realistic sensitivity value for the VSV-IN I-ELISA.
The I-ELISA may be suitable as a routine diagnostic method and may replace the CF and MTSN tests for screening bovine sera for antibodies to VSV-NJ and VSV-IN serotypes. However, the VSV I-ELISAs, as described here, cannot be applied to sera from other species (e.g., horses, pigs, wild ruminants, etc.). 34 Development of other ELISAs, e.g., competitive or blocking assays using VSV-specific monoclonal or polyclonal antibody similar to those reported previously, 1, 27 may provide a universal assay for screening sera from all species, including humans. 9 
